Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neo-Chance Study
NCT04196465Phase 2Active, not recruiting
- Sponsor
- Asan Medical Center
- Start
- Sep 2019
- Primary completion
- Sep 2028
- Modality
- CAR-T Cells, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of IMC-001 in gastric cancer (GC), esophageal cancer, hepatocellular carcinoma (HCC), sponsored by Asan Medical Center. Started Sep 2019; status: active, not recruiting.
02
Drugs
IMC-001
03
Conditions
gastric cancer (GC)esophageal cancerhepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT04196465.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04196465.